Evidence map›Paper›PMID 32565791›Full record

ArticleInternational journal of endocrinology2020

Germline Mutation in

Giuseppina De Filpo, Elisa Contini, Viola Serio, Andrea Valeri, Massimiliano Chetta, Daniele Guasti, Daniele Bani, Massimo Mannelli, Elena Rapizzi, Michaela Luconi and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of endocrinology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Giuseppina De FilpoDept. of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy.
Elisa ContiniCenter of Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, University of Florence, Florence, Italy.
Viola SerioDept. of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy.
Andrea ValeriGeneral and Surgical Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
Massimiliano ChettaA.O.R.N. Cardarelli, Medical Genetics, Pad. Y, Naples, Italy.
Daniele GuastiDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Daniele BaniDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.ORCID https://orcid.org/0000-0001-6302-901X
Massimo MannelliDept. of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy.ORCID https://orcid.org/0000-0002-8001-9857
Elena RapizziDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Michaela LuconiDept. of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy.ORCID https://orcid.org/0000-0001-5186-064X
Mario MaggiDept. of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy.
Tonino ErcolinoEndocrinology Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
Letizia CanuDept. of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy.ORCID https://orcid.org/0000-0003-4995-8108
Azienda Ospedaliero-Universitaria Careggi · ITUniversity of Florence · ITOspedale Antonio Cardarelli · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The genetic approach of pheochromocytomas and paragangliomas has changed in the last two decades. Nowadays, we know that more than 40% of patients have a germline mutation in one of the susceptibility genes identified to date. Our aim is to underline how genetic diagnosis by next-generation sequencing (NGS) can improve the management of patients affected by pheochromocytomas and paragangliomas in our routine diagnostic screening. We reported a case presentation and next-generation sequencing analysis supported by in silico studies and evaluation of mitochondrial status in

Identifiers

PMID32565791
PMCPMC7277055
OpenAlexW3029388820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.